Showing results (1701-1710 of 1,853) with videos related to
Sort By:
Pageof 186
Clinical Colorectal Cancer|September 3, 2018
Relationship Between Thymidine Kinase 1 Expression and Trifluridine/Tipiracil Therapy in Refractory Metastatic Colorectal Cancer: A Pooled Analysis of 2 Randomized Clinical TrialsTakayuki Yoshino, Kentaro Yamazaki, Eiji Shinozaki, et al.Digestion|June 6, 2018
The Role of an Undifferentiated Component in Submucosal Invasion and Submucosal Invasion Depth After Endoscopic Submucosal Dissection for Early Gastric CancerKoji Miyahara, Waku Hatta, Masahiro Nakagawa, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 27, 2020
Randomized, Phase II Study of Trastuzumab Beyond Progression in Patients With HER2-Positive Advanced Gastric or Gastroesophageal Junction Cancer: WJOG7112G (T-ACT Study)Akitaka Makiyama, Yasutaka Sukawa, Tomomi Kashiwada, et al.BMC Cancer|March 19, 2013
Transcriptional effects of 1,25 dihydroxyvitamin D(3) physiological and supra-physiological concentrations in breast cancer organotypic cultureCintia Milani, Maria Lucia Hirata Katayama, Eduardo Carneiro de Lyra, et al.Journal of Gastrointestinal Oncology|November 16, 2023
Identification of an optimal mutant allele frequency to detect activating KRAS, NRAS, and BRAF mutations in a commercial cell-free DNA next-generation sequencing assay in colorectal and pancreatic adenocarcinomasBennett A Caughey, Kumiko Umemoto, Michelle F Green, et al.Digestive Diseases (Basel, Switzerland)|May 17, 2019
Age Affects Clinical Management after Noncurative Endoscopic Submucosal Dissection for Early Gastric CancerMitsuru Esaki, Waku Hatta, Tooru Shimosegawa, et al.World Journal of Gastroenterology|April 24, 2019
Measurement of prostaglandin metabolites is useful in diagnosis of small bowel ulcerationsYuichi Matsuno, Junji Umeno, Motohiro Esaki, et al.The Lancet. Oncology|August 14, 2025
Health-related quality of life in patients with KRASG12C-mutated chemorefractory metastatic colorectal cancer treated with sotorasib plus panitumumab or standard of care (CodeBreaK 300): results from a phase 3, randomised clinical trialDominik Paul Modest, Marwan Fakih, Lisa Salvatore, et al.Digestive Diseases and Sciences|October 22, 2022
Safety and Efficacy of Sedation During Emergency Endoscopy for Upper Gastrointestinal Bleeding: A Propensity Score Matching AnalysisDaisuke Yamaguchi, Goshi Nagatsuma, Yasuhisa Sakata, et al.Frontiers in Public Health|October 10, 2022
Low SARS-CoV-2 viral load among vaccinated individuals infected with Delta B.1.617.2 and Omicron BA.1.1.529 but not with Omicron BA.1.1 and BA.2 variantsSivaprakasam T Selvavinayagam, Yean Kong Yong, Narcisse Joseph, et al.Pageof 186